French health care spending slowed markedly in March, after two months in which there was a flu epidemic and a surge in the number of cases of gastro-enteritis. Spending excluding hospital treatment rose 2.2% over March 2006 and contrasted with a 5.6% increase in February this year, according to figures from the health fund organization, the CNAM.
The CNAM has said it remains to be seen whether the slowdown constitutes a trend. Reimbursement rose 4.3% in the first quarter of 2007 over the same year-earlier quarter with a rise of 4.8% registered in general practice medicine. This compares with a target set by the Parliament of 1.1% growth.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze